NCT02230982 Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis Status NO_LONGER_AVAILABLE Phase N/A
NCT02187393 Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis Status WITHDRAWN Phase N/A
NCT02176707 Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase N/A
NCT02171156 Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP) Status APPROVED_FOR_MARKETING Phase N/A
NCT02168530 A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Status WITHDRAWN Phase PHASE2
NCT02141087 Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone Status APPROVED_FOR_MARKETING Phase N/A
NCT02136992 Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02135380 Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase PHASE1/PHASE2
NCT02085018 Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT02058602 Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase PHASE1
NCT02055456 Nandrolone Decanoate in the Treatment of Telomeropathies Status COMPLETED Phase PHASE1/PHASE2
NCT02052297 A Validation and Dosimetry Study of GSK2634673F PET Ligand Status TERMINATED Phase PHASE1
NCT02048644 Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Status COMPLETED Phase PHASE2
NCT02019641 The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease Status COMPLETED Phase NA
NCT02009293 The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT01979952 Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3